Eyenovia Inc
(NAS:EYEN)
$
0.77
0 (0%)
Market Cap: 41.48 Mil
Enterprise Value: 50.14 Mil
PE Ratio: 0
PB Ratio: 19.25
GF Score: 21/100 Eyenovia Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 26, 2023 / 05:00PM GMT
Release Date Price:
$1.64
(+4.46%)
Jennifer Kim Cantor Fitzgerald;Analyst
Okay. Good afternoon, everyone. Welcome to the Cantor Global Healthcare Conference. We're going to start our next panel.
I'm Jennifer Kim, a research analyst here at Cantor. I'm looking forward to hosting Eyenovia, Ocugen, and Tarsier Pharma for this ocular-themed panel. So thank you to all three of you for coming.
Michael Rowe Eyenovia
Inc. - CEO
Thank you.
Shankar Musunuri Ocugen
Inc. - Chairman of the Board, CEO, & Co-Founder
Thank you for having us.
Jennifer Kim Cantor Fitzgerald;Analyst
Maybe we could start off -- maybe we could go in a straight line. Could you introduce yourselves and give a brief overview of your company? So I guess, Shankar, we can start with you.
Shankar Musunuri Ocugen
Inc. - Chairman of the Board, CEO, & Co-Founder
Shankar Musunuri, Chairman and CEO, Co-Founder, Ocugen. We're a patient-centric biotech company focused on gene
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot